The At1g64760 gene encodes a glucan endo-1,3-beta-glucosidase, an enzyme involved in hydrolyzing β-1,3-glucans, which are key structural components of plant cell walls. This enzyme is implicated in developmental processes such as pollen maturation and stress responses .
| Protein Attribute | Detail |
|---|---|
| Gene Name | At1g64760 |
| UniProt ID | Q6NKW9 |
| Protein Function | Hydrolysis of β-1,3-glucans in plant cell walls during growth and stress |
| Species Reactivity | Arabidopsis thaliana (Mouse-ear cress) |
| Molecular Weight (Predicted) | ~70 kDa (varies by isoform) |
Western Blotting: Used to detect the ~70 kDa glucan endo-1,3-beta-glucosidase 8 protein in Arabidopsis extracts .
ELISA: Quantifies protein expression levels under varying experimental conditions (e.g., stress induction) .
Functional Studies: Investigates the role of β-1,3-glucan metabolism in pollen development and abiotic stress responses .
Specificity: The antibody’s specificity is inferred from its antigen-affinity purification, but users must validate it in their experimental systems (e.g., knockout controls) .
Cross-Reactivity: No cross-reactivity data are available; caution is advised when testing non-Arabidopsis species.
Mechanistic Studies: Elucidate the enzyme’s role in cell wall dynamics during plant-microbe interactions.
Agricultural Applications: Engineer crops with modified β-1,3-glucanase activity to enhance stress tolerance or biomass yield.
At1g64760 encodes the ATG6 protein in Arabidopsis thaliana, which plays critical roles in plant immunity and autophagy pathways. Recent research indicates that ATG6 directly interacts with NPR1 (Nonexpresser of Pathogenesis-Related genes 1), a key immune regulator, significantly enhancing plant resistance to pathogens such as Pseudomonas syringae . The antibody against this protein is essential for studying plant immune responses, autophagy mechanisms, and stress responses in Arabidopsis.
Validation of At1g64760 antibody should follow the "five pillars" of antibody characterization:
Genetic strategies: Use ATG6 knockout/knockdown lines as negative controls
Orthogonal strategies: Compare antibody-dependent results with antibody-independent methods
Multiple independent antibody strategies: Use different antibodies targeting distinct epitopes of ATG6
Recombinant strategies: Test with overexpressed ATG6 protein systems
Immunocapture MS strategies: Verify captured proteins using mass spectrometry
At minimum, researchers should document that the antibody: (i) binds specifically to the ATG6 protein; (ii) maintains specificity in complex protein mixtures; (iii) shows minimal cross-reactivity with other proteins; and (iv) performs consistently under the specific experimental conditions being used .
At1g64760 (ATG6) antibody is suitable for multiple applications including:
Western blotting to detect ATG6 protein levels
Immunoprecipitation to study ATG6 interactions (particularly with NPR1)
Immunofluorescence to visualize subcellular localization
Chromatin immunoprecipitation if studying DNA-binding complexes involving ATG6
Co-immunoprecipitation to verify protein-protein interactions
The antibody is particularly valuable for studying ATG6's role in promoting nuclear accumulation of NPR1 and formation of SA-induced NPR1 condensates (SINCs) .
Researchers should employ multiple complementary approaches to verify antibody specificity:
It's critical to document all validation steps in publications to enhance reproducibility .
To properly characterize ATG6-NPR1 interactions, researchers should employ:
Co-immunoprecipitation using At1g64760 antibody to pull down protein complexes
Reciprocal co-IP with NPR1 antibody
Proximity ligation assays to visualize interactions in situ
Bimolecular fluorescence complementation for in vivo interaction confirmation
Nuclear/cytoplasmic fractionation followed by immunoblotting to quantify NPR1 nuclear accumulation
These methods can verify that "ATG6 directly interacts with NPR1" and "ATG6 overexpression significantly increased nuclear accumulation of NPR1" .
When studying ATG6's impact on NPR1 nuclear localization, implement this experimental framework:
Generate and validate transgenic lines:
ATG6 overexpression lines
atg6 knockout/knockdown lines
NPR1-reporter fusions (e.g., NPR1-GFP)
Design appropriate treatments:
Mock treatment
Pathogen challenge (e.g., Pst DC3000/avrRps4)
Salicylic acid treatment at various concentrations
Cellular fractionation protocol:
Separate nuclear and cytoplasmic fractions
Quantify NPR1 in each fraction via western blotting
Use appropriate loading controls (nuclear and cytoplasmic markers)
Microscopy validation:
This approach provides multiple lines of evidence for ATG6's role in NPR1 nuclear accumulation.
Essential controls for At1g64760 antibody immunoprecipitation include:
Input sample: To verify protein presence before IP
Negative controls:
IgG control: Non-specific antibody of same isotype
Knockout/knockdown tissue: Material lacking the target protein
Pre-immune serum: When using polyclonal antibodies
Blocking peptide control: Pre-incubation with the immunizing peptide
Reciprocal IP: Pull-down with antibody against interacting partner (e.g., NPR1)
Denaturing controls: Testing interactions under denaturing conditions to distinguish direct vs. indirect interactions
These controls help distinguish specific signals from background and verify true protein-protein interactions.
To investigate ATG6's role in SA-induced NPR1 condensate (SINC) formation:
Prepare experimental systems:
Wild-type, ATG6-overexpression, and atg6 mutant plants
Treatment conditions: control vs. SA treatment at defined concentrations
Immunofluorescence approach:
Fix tissue samples with appropriate fixatives (e.g., 4% PFA)
Permeabilize tissues to allow antibody access
Co-stain with At1g64760 (ATG6) and NPR1 antibodies
Use confocal microscopy to visualize co-localization in nuclear condensates
Biochemical approach:
Perform nuclear isolation with varying salt concentrations
Analyze condensate properties through separation techniques
Immunoblot fractions to identify ATG6 and NPR1 co-segregation
Live-cell imaging:
These approaches can verify that "ATG6 can stabilize NPR1 and promote the formation of SINCs (SA-induced NPR1 condensates)-like condensates" .
Advanced techniques for tracking ATG6-NPR1 interaction dynamics include:
Single-molecule tracking:
Tag ATG6 and NPR1 with photoconvertible fluorophores
Monitor real-time movement and interaction in living cells
FRET/FLIM analysis:
Generate appropriate donor-acceptor fluorophore pairs
Measure energy transfer efficiency as indicator of molecular proximity
Quantify interaction changes over time post-pathogen exposure
Optogenetic approaches:
Create light-inducible ATG6 variants
Trigger ATG6 activation at precise timepoints
Monitor subsequent NPR1 relocalization
Super-resolution microscopy:
Use STED, PALM, or STORM techniques
Resolve subcellular structures below diffraction limit
Precisely map interaction domains within nuclear compartments
These techniques provide temporal and spatial resolution beyond conventional methods, revealing dynamic aspects of ATG6-NPR1 interactions during immune responses.
When facing inconsistent results with At1g64760 antibody:
Systematically assess variables:
Antibody batch variation: Test multiple lots
Sample preparation: Standardize extraction buffers, protease inhibitors
Experimental conditions: Temperature, incubation times, buffer composition
Tissue specificity: Different plant tissues may require optimized protocols
Validate antibody performance:
Re-test antibody specificity under your specific conditions
Consider epitope masking effects in different sample preparations
Evaluate potential post-translational modifications affecting epitope recognition
Establish positive controls:
Include samples with known high ATG6 expression
Consider using recombinant ATG6 protein as standard
Document all protocol variations:
Addressing variability through systematic troubleshooting enhances experimental reproducibility.
For rigorous analysis of ATG6-NPR1 co-localization data:
Quantitative co-localization metrics:
Pearson's correlation coefficient: Measures linear correlation between fluorescence intensities
Manders' overlap coefficient: Determines proportion of pixels with both signals
Object-based approaches: Count discrete structures showing both proteins
Appropriate statistical testing:
Compare coefficients across experimental conditions using ANOVA or appropriate non-parametric alternatives
Perform multiple comparison corrections (e.g., Bonferroni, Tukey HSD)
Report effect sizes alongside p-values
Sample size considerations:
Analyze multiple cells across independent biological replicates
Power analysis to determine minimum required measurements
Report sample sizes transparently
Control analyses:
Test for random co-localization by image randomization
Account for chromatic aberrations using technical controls
Include non-interacting protein pairs as negative controls
This statistical rigor prevents overinterpretation of coincidental co-localization and provides confidence in genuine biological interactions.
Emerging antibody technologies that could advance ATG6 research include:
Engineered "sweeping antibodies" with pH-dependent binding:
Single-domain antibodies (nanobodies):
Smaller size allows access to previously inaccessible cellular compartments
Can be expressed intracellularly as "intrabodies" to track ATG6 in living cells
Potential for higher specificity to particular ATG6 conformational states
Proximity-labeling antibody conjugates:
ATG6 antibodies conjugated to enzymes like BioID or APEX2
Enables identification of transient interaction partners in native contexts
Could reveal previously unknown components of ATG6-NPR1 complexes
These technologies could reveal new insights into the temporal and spatial dynamics of ATG6's role in plant immunity.